Heart Disease Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Disease
New heart disease study findings have been reported by scientists at Eastern Piedmont University
July 6th, 2008
According to recent research published in the International Journal of Cardiology, "Although stenting has been shown to reduce the need for target vessel revascularization (TVR) in acute myocardial infarction ( AMI), the benefits in terms of mortality and reinfarction are still unclear. Previous meta-analyses have failed to include all currently available randomized trials." "The aim of the current study was to perform an updated meta-analysis to evaluate the benefits of coronary stenting for AMI in terms of mortality, reinfarction, and TVR, and whether these benefits correlated with the patient's risk profile. The literature was scanned by formal searches of...
Source: Heart Disease Weekly (2008-07-06)
|
